ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $303,000 | -56.5% | 12,500 | -58.1% | 0.01% | -56.2% |
| Q4 2021 | $696,000 | -38.6% | 29,839 | -56.2% | 0.02% | -33.3% |
| Q3 2021 | $1,133,000 | -31.1% | 68,203 | +1.2% | 0.02% | -33.3% |
| Q2 2021 | $1,644,000 | -56.8% | 67,410 | -54.3% | 0.04% | -57.1% |
| Q1 2021 | $3,806,000 | -46.0% | 147,500 | +12.0% | 0.08% | -38.2% |
| Q4 2020 | $7,042,000 | +30.0% | 131,734 | +0.3% | 0.14% | -5.6% |
| Q3 2020 | $5,416,000 | +15.2% | 131,299 | +35.4% | 0.14% | +6.7% |
| Q2 2020 | $4,702,000 | +16.7% | 97,000 | +1.7% | 0.14% | -14.0% |
| Q1 2020 | $4,030,000 | -0.8% | 95,386 | +0.4% | 0.16% | +137.9% |
| Q4 2019 | $4,064,000 | +29.8% | 95,000 | +9.2% | 0.07% | +4.8% |
| Q3 2019 | $3,131,000 | +4.6% | 87,000 | -22.3% | 0.06% | -20.3% |
| Q2 2019 | $2,994,000 | -0.4% | 112,000 | 0.0% | 0.08% | +5.3% |
| Q1 2019 | $3,007,000 | +69.0% | 112,000 | +1.8% | 0.08% | +1.4% |
| Q4 2018 | $1,779,000 | -38.8% | 110,000 | -21.4% | 0.07% | -3.9% |
| Q3 2018 | $2,906,000 | +46.4% | 140,000 | +7.7% | 0.08% | +63.8% |
| Q2 2018 | $1,985,000 | +10.4% | 130,000 | +62.5% | 0.05% | -17.5% |
| Q1 2018 | $1,798,000 | +59.3% | 80,000 | +113.3% | 0.06% | +96.6% |
| Q4 2017 | $1,129,000 | +19.9% | 37,500 | +50.0% | 0.03% | -17.1% |
| Q3 2017 | $942,000 | +35.2% | 25,000 | 0.0% | 0.04% | +20.7% |
| Q2 2017 | $697,000 | -19.0% | 25,000 | 0.0% | 0.03% | -14.7% |
| Q1 2017 | $860,000 | +54.4% | 25,000 | +42.9% | 0.03% | 0.0% |
| Q3 2016 | $557,000 | -5.9% | 17,500 | -4.0% | 0.03% | -26.1% |
| Q2 2016 | $592,000 | -39.5% | 18,225 | -47.9% | 0.05% | +9.5% |
| Q1 2016 | $979,000 | -32.2% | 35,000 | -13.6% | 0.04% | -57.6% |
| Q4 2015 | $1,444,000 | +7.8% | 40,500 | 0.0% | 0.10% | +67.8% |
| Q3 2015 | $1,339,000 | -64.5% | 40,500 | -55.0% | 0.06% | -60.4% |
| Q2 2015 | $3,769,000 | +20.5% | 90,000 | -6.2% | 0.15% | +7.2% |
| Q1 2015 | $3,129,000 | -10.4% | 96,000 | -12.7% | 0.14% | +15.8% |
| Q4 2014 | $3,493,000 | +28.2% | 110,000 | 0.0% | 0.12% | +79.1% |
| Q3 2014 | $2,724,000 | +4.8% | 110,000 | -4.3% | 0.07% | +17.5% |
| Q2 2014 | $2,598,000 | +1.7% | 115,000 | +9.5% | 0.06% | +9.6% |
| Q1 2014 | $2,555,000 | +5.0% | 105,000 | +7.8% | 0.05% | 0.0% |
| Q4 2013 | $2,434,000 | -31.8% | 97,410 | -25.1% | 0.05% | +36.8% |
| Q3 2013 | $3,570,000 | +107.0% | 129,996 | +36.8% | 0.04% | -24.0% |
| Q2 2013 | $1,725,000 | – | 95,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |